Study suggests semaglutide affects aging beyond reduced calorie intake
The report frames the finding as evidence that the GLP-1 agonist acts through pathways separate from weight loss driven by eating less.
MH
By Maren Holt · Senior Reporter, GLP-1
Sep 22 03:01 ETSource: inc.com
The wire
- 01A new study suggests semaglutide may influence longevity through mechanisms that are not explained solely by reduced food intake, according to the report.
- 02Clinicians already field patient questions about GLP-1 use for aging; the distinction between weight-loss effects and independent pathways shapes how those questions are answered.
- 03The underlying study design, population and effect size are not detailed in the report, and longevity claims for semaglutide remain unproven in humans.
From the source
Read at inc.comA New Study Suggests Semaglutide Can Help Us Live Longer—And Not Just by Eating Less
